SELB NASDAQ
Selecta Biosciences, Inc.
1W: -25.9%
1M: -36.5%
3M: -40.4%
1Y: -47.9%
3Y: -79.4%
5Y: -87.9%
$0.88
Last traded 2023-12-11 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$296M
-31.9% ▼
5Y CAGR: +12.4%
Total Liabilities
$423M
-4.3% ▼
5Y CAGR: +18.2%
Shareholders Equity
-$126M
-1755.9% ▼
Cash & Investments
$125M
-41.1% ▼
5Y CAGR: -2.0%
Total Debt
$13M
-9.4% ▼
5Y CAGR: -18.5%
Net Debt
-$112M
+43.4% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $114M | $106M | $77M | $213M | $125M |
| Short-Term Investments | $14M | $28M | $0 | $0 | $0 |
| Cash & ST Investments | $128M | $135M | $77M | $213M | $125M |
| Net Receivables | $10M | $10M | $9M | $872K | $1M |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $6M | $4M | $5M | $3M | $3M |
| Total Current Assets | $144M | $148M | $91M | $217M | $129M |
| Property, Plant & Equip. | $12M | $14M | $12M | $15M | $18M |
| Goodwill & Intangibles | $0 | $0 | $48M | $48M | $48M |
| Long-Term Investments | $2M | $2M | $2M | $2M | $0 |
| Other Non-Current Assets | $1M | $1M | $152M | $153M | $101M |
| Total Non-Current Assets | $15M | $18M | $214M | $218M | $167M |
| Total Assets | $160M | $166M | $305M | $435M | $296M |
| — Liabilities — | |||||
| Accounts Payable | $224K | $316K | $3M | $288K | $1M |
| Short-Term Debt | $7M | $10M | $2M | $3M | $4M |
| Deferred Revenue | $54M | $593K | $2M | $0 | $0 |
| Other Current Liabilities | $11M | $14M | $61M | $20M | $11M |
| Total Current Liabilities | $72M | $25M | $68M | $23M | $15M |
| Long-Term Debt | $28M | $28M | $9M | $11M | $9M |
| Other Non-Current Liab. | $25M | $19M | $348M | $392M | $392M |
| Total Non-Current Liabilities | $65M | $47M | $376M | $419M | $408M |
| Total Liabilities | $137M | $72M | $445M | $442M | $423M |
| — Equity — | |||||
| Common Stock | $12K | $15K | $16K | $3K | $3K |
| Retained Earnings | -$430M | -$395M | -$615M | -$692M | -$822M |
| Accumulated OCI | -$5M | -$5M | -$5M | -$5M | -$5M |
| Total Stockholders Equity | $23M | $94M | -$440M | -$7M | -$126M |
| Total Liabilities & Equity | $160M | $166M | $305M | $435M | $296M |
| — Key Metrics — | |||||
| Total Debt | $35M | $38M | $11M | $14M | $13M |
| Net Debt | -$79M | -$69M | -$66M | -$199M | -$112M |
| Total Investments | $16M | $30M | $2M | $2M | $0 |